NEW ORLEANS – April 25, 2019 – Eclos, LLC, a Louisiana R&D company focused on CBD-based products with universal application and potential, has launched an exciting new product that uses natural elements of CBD to combat a global headache: the alcohol-induced hangover. Fittingly, CBDTOX Hangover Remedy, the nations’ first CBD-specific hangover product, was introduced this past February to its’ hometown of New Orleans, just in time for Mardi Gras.
“We’re excited about this new CBD-based product that provides an immediate response to the symptoms of a dreaded hangover,” said Jonathan Andry, co-founder of Eclos. “Compared to other products that claim to address the often negative impact of alcohol intake, CBDTOX is the first product to comprehensively target the entire range of hangover symptoms, including anxiety, irritability, and moodiness, the combination of which is often referred to as “hangxiety.”
CBDTOX Hangover Remedy is a patent pending mixture of CBD, and an antioxidant blend, and a blend of detoxifying agents, and a hydration recovery blend. The hemp-derived CBD used in CBDTOX delivers the desired relief, without the psychoactive effects of cannabis; thus, giving relief from alcohol’s “low” without the “high” of marijuana. By taking two capsules (one dose) per hangover, one can expect to experience reduced nausea and anxiety, increased energy and focus, and pain relief.
With some 2.6 billion U.S. hangovers each year, the demand for immediate relief is substantial. In response, herbal and dietary supplements specifically marketed as hangover treatments are projected to reach revenues of $2.1 billion in 2021, up from $1.6 billion in 2013. Now enter the hemp industry into the equation, with sales projections at $22 billion by 2022, and one can see the exciting potential in CBDTOX, the first-to-market CBD-based hangover remedy.
“Each day, millions of people are impacted by the negative side effects – directly or indirectly – of drinking alcohol,” said Dr. Tommy Bond, co-founder of Eclos. “Some people can’t even enjoy a glass of wine without the onset of a hangover the next morning,” he continued. “My hope is that CBDTOX can give people the confidence to socialize with the appropriate intake of alcohol and without the worry of its negative impact and lost productivity the next morning,” Bond concluded.